Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Regulated financial information

Prospectus

  • Read more about Prospectus

Bone Therapeutics reports 2014 financial and operational results

  • Read more about Bone Therapeutics reports 2014 financial and operational results

Bone Therapeutics Provides Business Update for the First Quarter 2015

  • Read more about Bone Therapeutics Provides Business Update for the First Quarter 2015

Bone Therapeutics announces half-year results for 2022

  • Read more about Bone Therapeutics announces half-year results for 2022

Listing prospectus

  • Read more about Listing prospectus

Bone Therapeutics Reports Full Year 2021 Results

  • Read more about Bone Therapeutics Reports Full Year 2021 Results

Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook

  • Read more about Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook

Bone Therapeutics Business Update for the Third Quarter of 2021

  • Read more about Bone Therapeutics Business Update for the Third Quarter of 2021

Listing Prospectus

  • Read more about Listing Prospectus

Bone Therapeutics announces half-year results for 2021

  • Read more about Bone Therapeutics announces half-year results for 2021

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Regulated financial information
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions